{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T18:33:29Z","timestamp":1782326009717,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002378"],"award-info":[{"award-number":["UL1TR002378"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA047365"],"award-info":[{"award-number":["R01DA047365"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpmfocus.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJPM Focus"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.focus.2024.100251","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T21:34:46Z","timestamp":1718228086000},"page":"100251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Concurrent Prescription Fills of Opioids and Benzodiazepines Among Postpartum Women During COVID-19"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7455-7464","authenticated-orcid":false,"given":"Amanda J.","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6615-1843","authenticated-orcid":false,"given":"Shelby R.","family":"Steuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Lawler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailemichael","family":"Shone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Bagwell","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.focus.2024.100251_bib0001","doi-asserted-by":"crossref","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.focus.2024.100251_bib0002","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.focus.2024.100251_bib0003","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am J Prev Med"},{"issue":"8","key":"10.1016\/j.focus.2024.100251_bib0004","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s11606-021-07035-6","article-title":"Benzodiazepine-involved overdose deaths in the USA: 2000\u20132019","volume":"37","author":"Kleinman","year":"2022","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.focus.2024.100251_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.focus.2024.100251_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.focus.2024.100251_bib0007","unstructured":"FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. U.S. Food and Drug Administration.https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or#:\u223c:text=Safety%20Announcement,or%20difficult%20breathing%20and%20deaths. Updated September 20, 2017. Accessed November 1, 2023."},{"key":"10.1016\/j.focus.2024.100251_bib0008","unstructured":"FDA requiring boxed warning updated to improve safe use of benzodiazepine drug class; includes potential for abuse, addiction, and other serious risks. U.S. Food and Drug Administration. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class. Updated February 10, 2020. Accessed November 1, 2023."},{"issue":"7","key":"10.1016\/j.focus.2024.100251_bib0009","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.7326\/M21-4656","article-title":"Trends in concurrent opioid and benzodiazepine prescriptions in the United States, 2016 to 2019","volume":"175","author":"Zhang","year":"2022","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.focus.2024.100251_bib0010","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2018.04.003","article-title":"Opioid prescribing patterns among postpartum women","volume":"219","author":"Badreldin","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"19","key":"10.1016\/j.focus.2024.100251_bib0011","doi-asserted-by":"crossref","first-page":"575","DOI":"10.15585\/mmwr.mm6919a2","article-title":"Vital signs: postpartum depressive symptoms and provider discussions about perinatal depression - United States, 2018","volume":"69","author":"Bauman","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.focus.2024.100251_bib0012","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.6438","article-title":"Comparison of postpartum opioid prescriptions before vs during the COVID-19 pandemic","volume":"6","author":"Steuart","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.focus.2024.100251_bib0013","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jpsychires.2022.04.011","article-title":"Rates of self-reported postpartum depressive symptoms in the United States before and after the start of the COVID-19 pandemic","volume":"151","author":"Bajaj","year":"2022","journal-title":"J Psychiatr Res"},{"issue":"20","key":"10.1016\/j.focus.2024.100251_bib0014","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1080\/14767058.2020.1843155","article-title":"COVID-19 pandemic and maternal mental health: a systematic review and meta-analysis","volume":"35","author":"Hessami","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.focus.2024.100251_bib0015","unstructured":"Opioid national drug code and Oral MME conversion file update. Centers for Disease Control and Prevention. https:\/\/archive.cdc.gov\/www_cdc_gov\/opioids\/data-resources\/index.html. Updated February 1, 2023. Accessed November 1, 2023."},{"issue":"7","key":"10.1016\/j.focus.2024.100251_bib0016","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jnci\/djz201","article-title":"Concurrent opioid and benzodiazepine prescriptions among older women diagnosed with breast cancer","volume":"112","author":"Check","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.focus.2024.100251_bib0017","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.6147","article-title":"Prescribing of opioid analgesics and buprenorphine for opioid use disorder during the COVID-19 pandemic","volume":"4","author":"Currie","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.focus.2024.100251_bib0018","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.31012","article-title":"Trends in the use of benzodiazepines, Z-hypnotics, and serotonergic drugs among US women and men before and during the COVID-19 pandemic","volume":"4","author":"Milani","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.focus.2024.100251_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2019.02.010","article-title":"Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing","volume":"199","author":"Strickler","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.focus.2024.100251_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109759","article-title":"Mandatory prescription drug monitoring programs and overlapping prescriptions of opioids and benzodiazepines: evidence from Kentucky","volume":"243","author":"Nguyen","year":"2023","journal-title":"Drug Alcohol Depend"}],"container-title":["AJPM Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773065424000695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773065424000695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:41:27Z","timestamp":1778935287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2773065424000695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2773065424000695"],"URL":"https:\/\/doi.org\/10.1016\/j.focus.2024.100251","relation":{},"ISSN":["2773-0654"],"issn-type":[{"value":"2773-0654","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concurrent Prescription Fills of Opioids and Benzodiazepines Among Postpartum Women During COVID-19","name":"articletitle","label":"Article Title"},{"value":"AJPM Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.focus.2024.100251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100251"}}